News
Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the effectiveness of oral contraceptives.
The tirzepatide Patient Information Leaflet advises that if you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine.” ...
While hair loss isn't a direct side effect listed in Mounjaro's package insert, a 2022 clinical trial showed that 4.9% to 5.7% of participants taking Mounjaro reported hair loss, compared to 0.9% ...
New research compared the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. Here's what the study found, and what a doctor has to say about it.
Any implementation of tirzepatide would need appropriate resource provided as well as ‘necessary training to safely take on any additional responsibility that comes their way.’ And it’s this ...
You can read the full publication in The Lancet Diabetes & Endocrinology, titled “Tirzepatide and muscle composition changes in people with type 2 diabetes: A post-hoc analysis from a randomised ...
Eli Lilly's tirzepatide has been shown to significantly cut cardiovascular risks in patients with obesity and a form of heart failure with few treatment options, in another big win for the GLP-1 ...
Ford's new Mustang FX package celebrates the beloved third-generation Fox body with '80s-inspired styling elements and nostalgic interior details for GT Premium models.
With the addition of 12.5 mg and 15 mg vials, all approved doses of Zepbound will be available in single-dose vials for $499/month or less, regardless of insurance status, under Zepbound Self Pay ...
Lilly now plans to file for approval to add the heart failure indication to the label for tirzepatide, which is already sold as Mounjaro for type 2 diabetes and Zepbound for obesity, later this year.
INDIANAPOLIS, June 16, 2025 /PRNewswire/ -- Eli Lilly and Company today announced that the highest approved doses of Zepbound (tirzepatide)—12.5 mg and 15 mg—will soon be available in single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results